CN103006723A - Medicine composition for treating facial acarodermatitis, and preparation method and use thereof - Google Patents
Medicine composition for treating facial acarodermatitis, and preparation method and use thereof Download PDFInfo
- Publication number
- CN103006723A CN103006723A CN2013100044217A CN201310004421A CN103006723A CN 103006723 A CN103006723 A CN 103006723A CN 2013100044217 A CN2013100044217 A CN 2013100044217A CN 201310004421 A CN201310004421 A CN 201310004421A CN 103006723 A CN103006723 A CN 103006723A
- Authority
- CN
- China
- Prior art keywords
- parts
- acarodermatitis
- facial
- pharmaceutical composition
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Abstract
The invention discloses a medicine composition for treating facial acarodermatitis, and a preparation method and a use thereof. The technical scheme of the invention has the key point that the medicine composition for treating facial acarodermatitis is a drug which is prepared by the following materials in parts by weight: 10-15 parts of wool fat, 3-5 parts of calamine, 2-4 parts of menthol, 50-55 parts of vaseline, 6-8 parts of paraffin wax, 13-16 parts of brucea javanica oil and 6-10 parts of biosulphur. The invention further discloses the preparation method and the use of the medicine composition for treating facial acarodermatitis. The traditional Chinese medicines are used as main active materials and compounds are used as auxiliary materials, so the medicine composition for treating facial acarodermatitis disclosed by the invention has the effects of treating both symptoms and root causes, a high curative ratio for the facial acarodermatitis, a low side effect of the drug reaction and strong drug performance, and can completely eliminate facial shallow long mites and deep short mites without easily recurring.
Description
Technical field
The present invention relates to a kind of pharmaceutical composition and its production and use, particularly a kind of pharmaceutical composition for the treatment of facial acarodermatitis and its production and use.
Background technology
Rosacea and comedo are a kind of common dermatosiss, and this disease not only affects the healthy of people, also can destroy the normal fitness of people's face skin, have brought mentally great worries for the patient.The similar drugs that also has in the market the facial acarodermatitis of several treatments, after these medicines use to the patient, effect is not clearly, especially can not thoroughly eradicate facial acarodermatitis, and the not good easy secondary recurrence of curative effect, analyzing its reason mainly is acarid not to be exterminated, and the short demodicid mite of dark type thoroughly can not be exterminated what is more, so easily recurrence.The root of comedo, rosacea is that facial shallow type is grown demodicid mite and dark type is lacked demodicid mite in the downward life of people's skin of face, facial comedo or the rosacea of causing for the period of development teenager.Therefore, be necessary to study a kind of pharmaceutical composition that can effectively treat comedo, rosacea, this facial acarodermatitis can thoroughly be cured, and thoroughly eradicate the long demodicid mite of facial shallow type and the short demodicid mite of the difficult dark type of eradicating, remove facial comedo or rosacea after the patient is used and be difficult for recurrence.
Summary of the invention
The technical problem that the present invention solves has provided a kind of pharmaceutical composition for the treatment of facial acarodermatitis, and this pharmaceutical composition can thoroughly be eradicated the long demodicid mite of facial shallow type and the short demodicid mite of the difficult dark type of eradicating, and can effectively cure acarodermatitis of human face.
Another technical problem that the present invention solves has provided its preparation method of the pharmaceutical composition of this treatment acarodermatitis, and this preparation method raw material is cheap and easy to get, and technique simply is easy to control.
The technical problem that the present invention also solves is this application of pharmaceutical composition in the symptoms such as treatment comedo, rosacea for the treatment of facial acarodermatitis, has preferably therapeutic effect.
Technical scheme of the present invention is: a kind of pharmaceutical composition for the treatment of facial acarodermatitis is characterized in that it is the medicament of being made by the raw material of following weight proportioning: 10 ~ 15 parts of lanolines, 3 ~ 5 parts of Calaminas, 2 ~ 4 parts of Mentholums, 50 ~ 55 parts in vaseline, 6 ~ 8 parts in paraffin, 13 ~ 16 parts of Oleum Fructus Bruceae, 6 ~ 10 parts of biochemical sulfur.
A kind of pharmaceutical composition for the treatment of facial acarodermatitis of the present invention is characterized in that it is the medicament of being made by the raw material of following weight proportioning: 13 parts of lanolines, 3.5 parts of Calaminas, 2.7 parts of Mentholums, 54 parts in vaseline, 6.8 parts in paraffin, 14 parts of Oleum Fructus Bruceae, 6 parts of biochemical sulfur.
A kind of pharmaceutical composition for the treatment of facial acarodermatitis of the present invention is characterized in that described medicament is cream.
A kind of preparation method for the treatment of the pharmaceutical composition of facial acarodermatitis, it is characterized in that: successively the raw material of following weight proportioning is joined in order with in heating and the container that stirs, wherein 10 ~ 15 parts of lanolines, 3 ~ 5 parts of Calaminas, 2 ~ 4 parts of Mentholums, 50 ~ 55 parts in vaseline, 6 ~ 8 parts in paraffin, 13 ~ 16 parts of Oleum Fructus Bruceae, 6 ~ 10 parts of biochemical sulfur, the heating and mix after namely get the cream drug compositions, then it is sent in 300 orders ~ 400 purpose grinders and grind, make the cream of the facial acarodermatitis for the treatment of.
A kind of preparation method for the treatment of the pharmaceutical composition of facial acarodermatitis, it is characterized in that: successively the raw material of following weight proportioning is joined in order with in heating and the container that stirs, wherein 13 parts of lanolines, 3.5 parts of Calaminas, 2.7 parts of Mentholums, 54 parts in vaseline, 6.8 parts in paraffin, 14 parts of Oleum Fructus Bruceae, 6 parts of biochemical sulfur, the heating and mix after namely get the cream drug compositions, then it is sent in 300 orders ~ 400 purpose grinders and grind, make the cream of the facial acarodermatitis for the treatment of.
The application of the pharmaceutical composition of the facial acarodermatitis for the treatment of of the present invention in treatment comedo, rosacea symptom, this pharmaceutical composition can be used for thoroughly eradicating the long demodicid mite of shallow type and the short demodicid mite of dark type.
The present invention is as main activated feedstock take Chinese crude drug, the pharmaceutical composition of the facial acarodermatitis of the treatment for preparing take chemical compound as auxiliary material, effect a permanent cure so can take stopgap measures, use this pharmaceutical composition high to the cure rate of facial acarodermatitis, and the drug reaction side effect is little, pharmaceutical properties is strong, can thoroughly eradicate the long demodicid mite of the shallow type of face and the short demodicid mite of dark type, and be difficult for recurrence.
The specific embodiment
The specific embodiment of form by the following examples, foregoing of the present invention is described in further details, but this should be interpreted as that the scope of the above-mentioned theme of the present invention only limits to following embodiment, all technology that realizes based on foregoing of the present invention all belong to scope of the present invention.
Embodiment
Take by weighing raw material (kilogram) by following weight proportion:
1, lanoline 10, Calamina 3, Mentholum 2, vaseline 50, paraffin 6, Oleum Fructus Bruceae 13, biochemical sulfur are 6 parts;
2, lanoline 13, Calamina 3.5, Herba Menthae powder 2.7, vaseline 54, paraffin 6.8, Oleum Fructus Bruceae 14, biochemical sulfur are 6 parts;
3, lanoline 15, Calamina 5, Herba Menthae powder 4, vaseline 55, paraffin 8, Oleum Fructus Bruceae 16, biochemical sulfur are 10 parts.
Production method is as follows:
Successively the raw material that takes by weighing is joined with in the container that heats and stir according to said sequence, the heating and mix after namely get the cream drug compositions, then it is sent in 300 orders ~ 400 purpose grinders and grind, make the cream of the facial acarodermatitis pharmaceutical composition for the treatment of.
Using method is as follows:
Use first the facial grease of warm water and neutral soap flush away, the cream rubbing that to treat facial acarodermatitis pharmaceutical composition after doing goes out in patient's face is ill, 2 ~ 3 times on the one, must not mix simultaneously use with other cosmetics in the use procedure, night, result of use was best, and be 60 ~ 80 days the general course for the treatment of.
Case 1:
Lee so-and-so, the woman, 21 years old, live Xinxiang County Li Zhuan, 17 years old facial comedo of giving birth to, repeatedly treatment is not healed, treat the cream of facial acarodermatitis pharmaceutical composition with this in July, 2008,4 days take effect, recovery from illness in 30 days was eradicated in 60 days.
Case 2:
The king so-and-so, the woman 23 years old, lives the king of counties and cities, Xinxiang, facial comedo was very serious in the middle school in 18 years old, was diagnosed as the short demodicid mite of the dark type in skin of face many places, treated the cream of facial acarodermatitis pharmaceutical composition with this in October, 2008,5 days take effect, and eliminate in 30 days, eradicate in 80 days, so far not recurrence.
Case 3:
Wu so-and-so, the woman 22 years old, lives Zhai Po, the student of Zhengzhou University, comedo is had one's face covered with very serious, the short demodicid mite of the dark type in skin of face many places, treat the cream of facial acarodermatitis pharmaceutical composition with this in April, 2011,5 days take effect, and all eliminate in 30 days, with the thoroughly radical cure in 80 days of this cream.
Above embodiment has described ultimate principle of the present invention, principal character and advantage.The technical staff of the industry should understand; the present invention is not restricted to the described embodiments; that describes in above-described embodiment and the description just illustrates principle of the present invention; under the scope that does not break away from the principle of the invention; the present invention also has various changes and modifications, and these changes and improvements all fall in the scope of protection of the invention.
Claims (6)
1. a pharmaceutical composition for the treatment of facial acarodermatitis is characterized in that it is the medicament of being made by the raw material of following weight proportioning: 10 ~ 15 parts of lanolines, 3 ~ 5 parts of Calaminas, 2 ~ 4 parts of Mentholums, 50 ~ 55 parts in vaseline, 6 ~ 8 parts in paraffin, 13 ~ 16 parts of Oleum Fructus Bruceae, biochemical sulfur 6 ~ 10.
2. the pharmaceutical composition of the facial acarodermatitis for the treatment of according to claim 1 is characterized in that it is the medicament of being made by the raw material of following weight proportioning: 13 parts of lanolines, 3.5 parts of Calaminas, 2.7 parts of Mentholums, 54 parts in vaseline, 6.8 parts in paraffin, 14 parts of Oleum Fructus Bruceae, 6 parts of biochemical sulfur.
3. according to claim 1, the pharmaceutical composition of the facial acarodermatitis of 2 described treatments, it is characterized in that described medicament is cream.
4. the preparation method of the pharmaceutical composition of the facial acarodermatitis for the treatment of claimed in claim 1, it is characterized in that: successively the raw material of following weight proportioning is joined in order with in heating and the container that stirs, wherein 10 ~ 15 parts of lanolines, 3 ~ 5 parts of Calaminas, 2 ~ 4 parts of Mentholums, 50 ~ 55 parts in vaseline, 6 ~ 8 parts in paraffin, 13 ~ 16 parts of Oleum Fructus Bruceae, 6 ~ 10 parts of biochemical sulfur, the heating and mix after namely get the cream drug compositions, then it is sent in 300 orders ~ 400 purpose grinders and grind, make the cream of the facial acarodermatitis for the treatment of.
5. the preparation method of the pharmaceutical composition of the facial acarodermatitis for the treatment of claimed in claim 2, it is characterized in that: successively the raw material of following weight proportioning is joined in order with in heating and the container that stirs, wherein 13 parts of lanolines, 3.5 parts of Calaminas, 2.7 parts of Mentholums, 54 parts in vaseline, 6.8 parts in paraffin, 14 parts of Oleum Fructus Bruceae, 6 parts of biochemical sulfur, the heating and mix after namely get the cream drug compositions, then it is sent in 300 orders ~ 400 purpose grinders and grind, make the cream of the facial acarodermatitis for the treatment of.
6. the application of the pharmaceutical composition of claim 1, the facial acarodermatitis of 2 described treatments is characterized in that: described pharmaceutical composition can be used for eradicating the long demodicid mite of facial shallow type and the short demodicid mite of dark type.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100044217A CN103006723A (en) | 2013-01-07 | 2013-01-07 | Medicine composition for treating facial acarodermatitis, and preparation method and use thereof |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN2013100044217A CN103006723A (en) | 2013-01-07 | 2013-01-07 | Medicine composition for treating facial acarodermatitis, and preparation method and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN103006723A true CN103006723A (en) | 2013-04-03 |
Family
ID=47956186
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN2013100044217A Pending CN103006723A (en) | 2013-01-07 | 2013-01-07 | Medicine composition for treating facial acarodermatitis, and preparation method and use thereof |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN103006723A (en) |
Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1234226A (en) * | 1999-05-17 | 1999-11-10 | 孔凡利 | Mite-killing face-beauty cream |
| CN1739563A (en) * | 2005-09-08 | 2006-03-01 | 马建国 | Medicated cream and its prepn process |
-
2013
- 2013-01-07 CN CN2013100044217A patent/CN103006723A/en active Pending
Patent Citations (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1234226A (en) * | 1999-05-17 | 1999-11-10 | 孔凡利 | Mite-killing face-beauty cream |
| CN1739563A (en) * | 2005-09-08 | 2006-03-01 | 马建国 | Medicated cream and its prepn process |
Non-Patent Citations (1)
| Title |
|---|
| 庞庆添: "复方炉甘石洗剂治疗螨虫皮炎120例", 《现代医药卫生》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2008140200A1 (en) | External compositions for the skin | |
| CN103054989B (en) | Compound essential oil for preventing and treating psoriasis as well as preparation method thereof | |
| CN103070961A (en) | Chinese medicinal anti-bacteria health care foot-massage solution and preparation method thereof | |
| CN103007123A (en) | Health-care traditional Chinese medicinal composition for hand and foot rhagadia | |
| CN101143166B (en) | Medicine for swelling and relieving pain and its preparation method and application | |
| CN101259149A (en) | Tinctura for treating beriberi | |
| CN101879219A (en) | Chinese medicinal composition for treating mastitis of dairy cattle and preparation method thereof | |
| CN110731953A (en) | Traditional Chinese medicine compound cataplasm for treating qi-stagnation and blood stasis type cervical spondylosis and preparation method thereof | |
| CN105521211A (en) | Traditional Chinese medicinal ointment rubbing agent for promoting growth of premature low-birth-weight children, and preparation method thereof | |
| CN105125708B (en) | A kind of pharmaceutical composition and preparation method thereof for rhinitis | |
| CN103800401A (en) | Granulation promoting and healing ointment | |
| CN103006723A (en) | Medicine composition for treating facial acarodermatitis, and preparation method and use thereof | |
| CN102743506A (en) | Camellia japonica oil acne lotion and preparation method thereof | |
| CN103223081A (en) | Grass oil for treating arthritis and traumatic injury | |
| CN103784893B (en) | A kind of medicine for the treatment of cerebral apoplexy sequela | |
| CN102266408B (en) | Use of gardenia extract and borneol effective ingredients in Chinese medicine preparation for intervening in cutaneous prutitus | |
| CN100409877C (en) | Chinese medicine preparation for treating hyperosteogeny | |
| CN102755608B (en) | External application medicine for treating bronchitis | |
| CN104258097A (en) | Anti-inflammatory and analgesic balm | |
| CN104027505A (en) | Method for preparing traditional Chinese medicine facial mask powder for treating pimple | |
| CN103272210A (en) | Pharmaceutical composition for treating osteoarthrosis and brucellosis and preparation method thereof | |
| CN104147045A (en) | Plaster for effective treatment of foot ulcer | |
| CN103656526B (en) | A kind of Chinese medicine composition being used for the treatment of eczema and skin pruritus | |
| CN103705629B (en) | A kind of Chinese medicine composition for the treatment of pruritus | |
| CN103908508B (en) | A kind of beriberi rehabilitation medicament |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C02 | Deemed withdrawal of patent application after publication (patent law 2001) | ||
| WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20130403 |